Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by newdaydawningon Mar 23, 2019 8:56pm

169 Views

Post# 29527881

RE:Not shorting who are you kidding

Enbulletin publishes rubbish, like this completely false statement:

"Since March 20, 2018 TLTFF has 0.00% and is . The stock underperformed the S&P500 by 4.37%."

In fact, TLTFF has more than doubled during that period, outperforming the S&P 500 by more than an order of magnitude.

BDM, your sources can't be trusted.

billiondolarman wrote: State side Theralase is up on the short side of more than 50%. Check out the link>>>>>BDM
Research before you make statements that are false!!!
https://enbulletin.com/2019/03/20/on-mar-20-2019-theralase-technologies-inc-ordinary-shar-otcmktstltff-shorts-rose-by-50-62/

Bullboard Posts

Corus reports Q1 profit drop in the face of falling revenue